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Abstract 
 
Background & aims: Overweight polycystic ovary syndrome (PCOS) patients present 
exacerbation of clinical symptoms and increased risk for chronic diseases. The effects 
of inadequate dietary intake have been investigated in body weight gain in PCOS 
women. The aim of this study was to evaluate the dietary pattern and to analyze 
possible associations with the metabolism and body composition in PCOS women. 
Methods: A case-control study was performed with thirty-nine women diagnosed with 
PCOS and thirty-five control women, matched by age and body mass index. A body 
composition assessment was performed by Dual-energy X-ray absorptiometry (DXA) 
and food intake was assessed using the seven-day food record. The metabolic 
parameters evaluated were fasting glucose, insulin, Homeostasis Model Assessment-
estimated Insulin Resistance (HOMA-IR) index and oral glucose tolerance test 
(OGTT).  
Results: No significant differences were observed in dietary intake of women with or 
without PCOS. In the analysis of the associations between dietary intake, metabolic 
parameters and body composition, PCOS women showed an inverse correlation 
between dietetic fiber intake and HOMA-IR index (p=0.024; r=-0.365). Also in PCOS 
group, dietary fiber intake presented an inverse correlation with total body fat (p=0.011, 
r=-0.401), trunk fat (p=0.015, r=-0.388), and android fat (p=0.006; r=-0.431). PCOS 
women group had higher glucose 120’, compared to those without PCOS (p=0.015) 
Conclusion: These results provide evidence that the adequate intake of dietary fiber 
contributes to more appropriate body composition and glucose metabolism in PCOS 
women and possibly toward the prevention of chronic non-communicable diseases. 
 
 
 
Keywords: Polycystic ovary syndrome; Dietary pattern; Body composition; Dual-
energy X-ray absorptiometry; Metabolic parameters.
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1. Introduction 
Polycystic ovary syndrome (PCOS) is a common endocrine disease. PCOS 
affects 4 to 8% of women during reproductive age through the criteria put forward by 
the National Institutes of Health (NIH) or 14% to 19% in line with the European Society 
of Human Reproduction and Embryology and the American Society for Reproductive 
Medicine (ESHRE/ASRM)1,2,3,4. Although the responsible causal factors for the 
development of PCOS are still not totally clear, some researchers have demonstrated 
the involvement of genetic and environmental factors5,6,7,8. 
PCOS is essentially characterized by the presence of physiopathological 
alterations typical of metabolic syndrome, with emphasis placed on insulin resistance 
and hyperinsulinemia3,9. The presence of these dysfunctions increases the risk of 
developing type 2 diabetes and cardiovascular diseases, among other diseases 
associated with metabolic alterations10. 
Specifically to body composition, women with PCOS present a high overweight 
ratio. Although there is no consensus reached in the literature11,12, some investigators 
have demonstrated that patients with PCOS present an increase in central abdominal 
fat when compared to controls matched by body weight13,14. According to Carmina et 
al.13, this difference was not observed when comparing obese PCOS and the obese 
control group, i.e., the increase of central abdominal fat is due to the differences found 
between the control group and the eutrophic or overweight PCOS patients13. 
Overweight PCOS patients, mainly those with central obesity, present less sensibility 
and elevated serum insulin levels, exacerbation of clinical symptomatology and a 
higher risk for chronic non-communicable diseases14,15,16. 
Inadequate food intake in qualitative and quantitative terms have been 
investigated as one of the casual factors responsible for the excess body weight in 
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women with PCOS17. In a study evaluating food intake by means of a semi-quantitative 
food intake questionnaire, it was demonstrated that women with PCOS present a 
higher total energy and fat consumption18. The aims of the present study were to 
characterize the dietary pattern and analyze possible associations between the 
consumption of specific nutrients with metabolic parameters and body fat distribution 
in women with PCOS.     
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2. Participants and Methods 
2.1 Participants 
This case-control study was performed at the Endocrine Gynecology Outpatient 
of the Clinical Hospital of Uberlandia, Federal University of Uberlandia, Brazil, between 
September 2015 to May 2017.   
The study participants were recruited by means of pamphlets posted in strategic 
locations of the campus, email and verbal communication. Potential study participants 
were instructed to present their medical histories, as well as being submitted to a 
genealogical exam. In order to determine ovarian morphology, a two-dimensional 
pelvic or transvaginal ultrasound exam was performed.  
Thirty-nine women were included in the study, all ranging between 18 and 35 
years of age, and all diagnosed with PCOS, as they presented two or more criteria 
from the  Rotterdam consensus19: oligomenorrhea and/or anovulation; clinical signs 
and/or biochemical hyperandrogenism; and/or polycystic ovaries on an ultrasound 
exam. Ovaries were characterized as polycystic through an ultrasound exam, and 
present one of the following alterations: 12 or more follicles measuring between 2-9mm 
in diameter or with increased ovary volume (≥10 cm3), on at least one of the ovaries20. 
The presence of oligomenorrhea and/or anovulation was identified by the occurrence 
of the menstrual cycle with a duration of > 38 days21. Hyperandrogenism was identified 
through the presence of acne in the physical exam and/or hirsutism (score for 
Ferriman-Gallwey ≥ 8)22.  
Thirty-five women were included in the control group, with ages between 18 and 
35, all presented regular and spontaneous menstrual cycles and who did not present 
any previous history of infertility. All the women included in the control group were 
matched by age and Body Mass Index (BMI) with women with PCOS. In the clinical 
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practice, in order to perform the pairing, a difference of up to ± 2.0 kg/m2 on the BMI 
was used as the criterion, while observing that each control had the same BMI category 
as the recruited PCOS patient (WHO, 2000)23.   
Immediately after the inclusion of the study participants, an anthropometric 
evaluation was performed and information was collected for the filling out of a semi-
structured questionnaire. The collection of blood samples for performing biochemical 
exams (fasting glucose, basal insulin, and after glucose challenge test), and the body 
composition evaluation using the Dual-energy X-ray absorptiometry (DXA) were 
performed in specialized clinics at a later moment.  
 Were excluded from the study those patients that had been taking any kind of 
hormonal medication over the last three months, or oral hypoglycemic agents, or 
medication for inducing weight loss; those diagnosed with other endocrinological 
diseases (congenital adrenal hyperplasia, hypothyroidism or hyperthyroidism, 
hyperprolactinemia, Cushing's syndrome, androgen secreting tumors or other related 
disorders); pregnant women or breast feeding mothers.   
All the participants of the study signed the term of free and informed consent. 
The study was conducted according to the guidelines established in the Declaration of 
Helsinki, after being approved by the Ethics Committee for Research on Human beings 
at the Federal University of Uberlandia.  
 
2.2 Study protocol 
A specific and semi-structured questionnaire was created with information 
pertinent to diet history, including preferences and food aversions, intolerances or food 
allergies, standards of chewing, habitual daily water intake and use of dietary 
supplements. In addition, were investigated the intestinal habits and the history of the 
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evolution for their body weight. General and sociodemographic information, along with 
personal history and family history were also registered.  
 
2.3 Anthropometric evaluation 
Were taken measurements for body weight, height, waist circumference 
(measured at the midpoint between the last costal arch and the iliac crest) and the 
circumference of the hip (measured along the largest diameter of the gluteal region). 
Following this, the BMI was calculated.  
For body weight measurements, a digital scale was used (Welmy W300, 
precision of 0.1 kg). During the weighing process, the patient was barefoot, erect and 
stood in the center of the platform with her arms close to the body, eyes fixed at a point 
in front of her, and with the least amount carried objects as possible. The height 
measurement (precision of 0.5 cm) was taken on a vertical anthropometer coupled to 
the digital scale. The patient remained upright, barefoot, in the center of the platform 
with their back to the marker and heels together and their feet at an angle of 45 
degrees. The patient kept their arms down and their head back, looking at a fixed point 
at eye height. The BMI was calculated by the formula: body weight (kg) / height (m)² 
and was classified according to references from the World Health Organization21. The 
value of the waist circumference was obtained from the average of three 
measurements taken with an inextensible anthropometric tape (Sanny Medical, SN-
4010, precision of 0.5 cm) at the midpoint point between the last costal arch and the 
iliac crest arch. The hip circumference (precision of 0.5 cm) was measured in the region 
localized between the waist and the thighs, at the point of largest diameter.   
 
2.4 Evaluation of body composition 
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The evaluation body composition was performed using DXA of the whole body 
(Lunar Prodigy DXA System, software version 11.20). After the removal of all metallic 
objects, a radiologist technician performed the exam. Measurements were made 
regarding the amount of fat body mass and lean body mass, along with the obtainment 
of information concerning the distribution of body fat in the android and trunk 
compartments. More specifically, were identified the compartments relevant to the 
android fat (lower limit: horizontal line connecting the upper anterior superior iliac 
spines; upper limit: defined as 20% above the lower border; lateral boundaries: waist 
margins parallel to the chin line) and the trunk fat (defined by a horizontal line below 
the chin and vertical lines passing through colli femori). Was calculated the ratio 
between the fat mass and lean mass (fat mass (%) / lean mass (%)). 
  
2.5 Evaluation of food intake 
The dietary pattern was determined by the seven-day food report24. The 
participants were guided to fill in the time and place of meals taken, the quantity and 
the type of food or preparation and drinks ingested. At the moment of devolution of the 
food register, each described item was conferred with the patient in question. In 
accordance with the seven-day food report, the total energy ingested and the quantities 
consumed for carbohydrates, proteins, fat, saturated fatty acids, cholesterol and fiber 
were all identified.   
 
2.6 Biochemical analyses  
The blood samples used for performing the biochemical analyses were obtained 
after a 12-hour fasting. The serum levels of total cholesterol, HDL cholesterol, LDL 
cholesterol and triglycerides (enzymatic colorimetric method, Roche Diagnóstica©, 
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Brazil) were evaluated. In addition, the simplified oral glucose tolerance test (OGTT) 
was performed, in two screenings, with the first in fasting and the second two hours 
after the ingestion of 75g of glucose. The serum blood glucose levels (hexokinase 
method Roche Diagnóstica©, Brazil) and of basal insulin (chemiluminescence, Roche 
Diagnóstica©, Brazil) were evaluated. The Homeostatic Model Assessment for Insulin 
Resistance (HOMA-IR) index was calculated using the formula: HOMA-IR = fasting 
glucose (mg/dL) x fasting insulin (µUI/mL) / 40525. 
 
2.7 Statistical analysis 
The statistical analysis was performed using the software SPSS version 21.0 
(Armonk, NY: IBM Corp.). The results were represented as mean ± standard deviation 
(SD) in the case of parametric data and as the median and confidence interval (CI 
95%) for non-parametric data. The Student t test was used for analyzing the 
anthropometric measurements (weight, height, BMI, waist and hip circumference) and 
the metabolic parameters (fasting glucose, basal insulin, HOMA-IR index and after 
glucose challenge test), and the body composition measurements (total fat, trunk fat, 
and android fat). The comparisons among the non-parametric results were carried out 
using the Mann-Whitney U test. Comparisons were made in order to identify if after the 
separation of the participants into specific subgroups, in accordance with the BMI 
classification proposed by WHO21, were maintained the interpretations referring to the 
dietary parameters (energy intake, carbohydrate, protein, lipid, saturated fatty acids, 
cholesterol and fiber) and the distribution of body fat (total fat, trunk fat, and android 
fat), using the test of Kruskal-Wallis (1-way ANOVA). The Spearman coefficient was 
used to analyze the correlations between energy intake and nutrients with the 
metabolic parameters and the body composition of women with and without PCOS. 
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Statistical significance was considered as p ≤ 0.05, through the adoption of the two-
tailed test. 
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3. Results 
Anthropometric and some metabolic parameters of the PCOS and their BMI and 
age-matched control group were presented on Table 1. No significant differences were 
observed in weight, BMI, waist, hip, fasting glucose, fasting insulin, HOMA-IR index 
between the PCOS and control groups. The PCOS group had higher glucose 120’, 
when compared to those without PCOS (p=0.015) (Table 1).  
In relation to body composition, it was identified that total body fat, trunk fat, and 
android fat were similar in PCOS and control groups (Table 1). In the comparisons 
performed between the participants included in the PCOS subgroups eutrophic (n=20) 
and eutrophic control (n=19) (BMI = 18.5 to 24.9 kg/m²); and overweight PCOS (n=19) 
and overweight control (n=16) (BMI ≥ 25.0 kg/m²), it was demonstrated that total fat 
(p=0.000), trunk fat (p=0.000), and android fat (p=0.000) were higher in overweight 
women than eutrophic women, with (p=0.000) or without (p=0.000) PCOS. 
The dietary pattern of eutrophic and overweight women with or without PCOS 
was presented on Table 2. No significant differences were observed in dietary intake 
of women with or without PCOS. Comparable results were observed in specific 
subgroups, i.e., eutrophic women subgroup and overweight women subgroup, with or 
without PCOS, had similar dietary patterns. Specifically in the PCOS group, for results 
expressed by kilogram of weight, it was identified that overweight women consumed 
less energy (p=0.001), carbohydrate (p=0.012), protein (p=0.031), fat (p=0.047) and 
fibers (p=0.006) than normal weight PCOS women. In the group without PCOS, for 
results expressed by kilogram of weight it was observed that overweight women 
consumed lower amounts of energy (p=0.022), protein (p=0.004) and cholesterol 
(p=0.004) than eutrophic women without PCOS. 
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There was a positive correlation between dietary protein (p=0.037; r=0.359), fat 
(p=0.005; r=0.005), saturated fatty acids (p=0.022; r=0.022) and fiber intake (p=0.039; 
r=0.356) with the after glucose challenge test of women without PCOS (Table 3). In 
the analysis of the associations between dietary intake, metabolic parameters and 
body composition, PCOS women showed an inverse correlation between dietary fiber 
intake and the HOMA-IR index (p=0.024; r=-0.365), i.e., the higher the fiber intake, the 
lower the HOMA-IR index value was observed in PCOS women. In addition, for a 
similar fiber intake in women with and without PCOS, the range of HOMA-IR index 
values is higher in PCOS than in control groups (Fig. 1A and 1B). 
In PCOS group, dietary fiber intake presented an inverse correlation with total 
body fat (p=0.011; r=-0.401), trunk fat (p=0.015; r=-0.388), and android fat (p=0.006; 
r=0.431) (Table 3). The relationship between fiber intake and visceral adiposity 
(android fat) in both groups is shown in Fig. 1C and 1D. 
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4. Discussion 
The present study demonstrated that women with PCOS present a negative 
correlation between the consumption of dietary fiber and resistance to insulin, i.e., the 
higher the consumption of fiber, greater will be the insulin sensitivity presented by the 
patient. The least resistance to the action of insulin associated with consumption of 
dietary fiber identified in basal conditions in women with PCOS is lost in time 120 
minutes of the OGTT.  These results permit the interpretation that to obtain a better 
metabolic control in PCOS women, they should be guided toward the regular daily 
consumption of the recommended quantities of dietary fiber (20 to 35 g/dia)26, as well 
as the restriction in the consumption of sugar and sweet foods. It is important to 
highlight that these guidelines are included in the dietary recommendations for healthy 
individuals, elaborated by responsible organs from a number of countries27, including 
the Alimentary Guide for the Brazilian Population, proposed by the Brazilian Ministry 
of Health28.  
Few researchers have investigated the relationship between food intake, 
metabolic parameters and body composition in women with PCOS. In the present 
study, it was demonstrated, exclusively for PCOS women, that dietary fiber intake is 
negatively associated with body composition, in particular in terms of central fat, i.e.,  
a body composition parameter that has been specifically investigated in women with 
PCOS12,13,15. In agreement with these results, Nybacka et al.29 identified that the 
increase in the intake of dietary fiber in women with PCOS presents a negative 
correlation with the increase in BMI. According to these researchers, the increase in 
dietary fiber intake is a primary predictor to the reduction in the BMI.     
In the present study, it was demonstrated that women with PCOS and 
investigated controls, presented a similar ingestion of energy, macronutrients, 
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saturated fatty acids, cholesterol and fiber. These results confirm those of previous 
studies that also did not identify differences in food consumption, between women with 
and those without PCOS30,31. 
In the specific analysis concerning food intake for the subgroups made up of 
overweight women and eutrophic women, with or without PCOS, it was identified that 
regardless of the diagnosis of PCOS, the participants from the overweight subgroups 
present lower energy and macronutrient food intake (expressed in kilocalories / kg of 
body weight), than the participants of the eutrophic subgroups. Several factors should 
be analyzed in an attempt to explain these results. Initially, it is necessary to consider 
that due to higher body mass, overweight patients may present a reduction in habitual 
physical activity, with a consequent decrease in daily energy expenditure32. Another 
possibility is that due to the alteration in body composition, with an increase in fat mass 
/ lean mass ratio, there is a decrease in the metabolic rate and the daily energy needs, 
i.e., overweight patients may actually present a decrease in daily energy intake 
expressed in kilocalories / kg of current body weight33. In addition, it is necessary to 
consider that although there exist many advantages to using the seven-day food 
report23, those patients with excess weight, with or without PCOS, may have 
intentionally given an underreporting of food intake34. 
In the comparison with matched controls by BMI and age, the PCOS patients 
included in the present study showed similar values for the measurements taken using 
DXA for total fat, trunk fat, and android fat.  All overweight patients, independent to 
being part of the PCOS group or not, presented a higher quantity of total body fat, trunk 
fat, and android fat. In addition, there were no differences identified in the body fat of 
eutrophic women, with or without PCOS. These results confirm those of previous 
studies that did not identify differences in the quantities and in the distribution of body 
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fat between women with PCOS and control groups11. However, it is necessary to 
highlight that there still does not exist a consensus in the literature concerning this 
question. In disagreement with the results presented in this study, Carmina et al.13 
identified that central abdominal fat was increased by 30% in eutrophic PCOS women 
and 71% in overweight PCOS women, in comparison to 50% of the control women 
without PCOS. Higher central fat mass in PCOS women compared with control groups 
was also demonstrated by Glintborg et al.15. 
As particular strengths in this study, one can highlight the use of the seven-day 
food report, an instrument that presents higher accuracy in estimating habitual food 
intake of individuals. Another feature is the use of a variety of parameters for evaluating 
possible metabolic alterations, including the HOMA-IR index, as well as the use of the 
DXA for evaluating body composition.  The limitations of the study are related to the 
observational study design, as it is not possible to attribute causality in the results 
found, although there were associations identified between the consumption of fiber, 
metabolic parameters and body composition in PCOS women. It is hoped that in future 
clinical studies, it will be the effect of consuming adequate dietary fiber on the 
metabolism and body composition of PCOS patients.    
In conclusion, the systematic guidance toward the adequate consumption of 
dietary fiber, considering as source foods the fruits, leafy vegetables and grains, 
contributes to adequate body composition, the control of the glucose metabolism and 
possibly to the prevention of chronic non-communicable diseases in PCOS women.
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Table 1 Anthropometric, metabolic and body composition features of the study 
participants. 
 
Data were represented as means ± standard deviation (SD) or median and 95% 
Confidence Interval (CI). Abbreviations: BMI: Body Mass Index; HOMA-IR: 
Homeostasis Model Assessment-estimated Insulin Resistance. Statistical 
comparisons were performed by Student t test for means and by Mann-Whitney U test 
for medians (P value ≤ 0.05).
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Table 2 Dietary pattern of women with and without PCOS.  
 
Data were represented as median and 95% Confidence Interval. Abbreviations: SFA: Saturated Fatty Acid. Statistical comparisons 
were performed by Kruskal-Wallis 1-way ANOVA test (P value ≤ 0.05).
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Table 3 Relations between the food intake, metabolic parameters and body composition of women with and without PCOS. 
 
Abbreviations: SFA: Saturated Fatty Acid; HOMA-IR: Homeostasis Model Assessment-estimated Insulin Resistance. Analysis by 
Spearman’s correlation coefficient (P value ≤ 0.05).
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Fig. 1 Association between the fiber intake and HOMA-IR of women with PCOS (A) 
and controls (B), and association between the fiber intake and android fat of women 
with PCOS (C) and controls (D). Analysis by Spearman’s correlation coefficient (P 
value ≤ 0.05). 
